Glossary of Inherited Genes and Hereditary Syndromes  

If you have an inherited genetic variant in a tumor suppressor gene or a hereditary syndrome, it does not guarantee that you will get cancer. It does mean that you have a greater risk of developing a certain type of cancer than the general population. 

An inherited genetic variant or hereditary syndrome is a risk factor that can help inform your healthcare. Risk factors are not the same as a diagnosis, and risk factors do not only come from inheriting a genetic condition. Other factors may elevate your cancer risk, such as smoking, drinking alcohol, previous cancer treatments, or chemical exposure, to name a few. 

Knowing that you have one of these genetic variant or inherited conditions can guide your treatment plans and help with family planning. Genetic counselors might advise closer monitoring or regular screenings, so doctors can catch cancer earlier if it does develop. They advise this because catching cancer earlier increases the odds of experiencing positive treatment outcomes. 

Disclaimer:

Genetic scientists are constantly learning new things about genes and chromosomes and the way they function in our DNA. Knowledge about these genetic behaviors is bound to change over time as more discoveries are made. 

The material included here is for informational purposes only and does not replace making an appointment with a genetic counselor for medical advice. They can discuss your specific conditions and review treatment, preventive measures, and surveillance options that work best for you and your family. 

Tumor Suppressor Genes and Proto-Oncogenes 

When tumor suppressor genes function normally, they help prevent cells from rapid division, correct mistakes during DNA replication, or tell cells when to self-destruct. If a mutation occurs in a gene or a pathogenic variant happens (a change in the gene that causes disease), the gene can lose its ability to control cell division and behavior. If a cell error repeats during division, or if cells start to divide rapidly without some being eliminated, it can lead to cancer. 

People who are born with a pathogenic variant (also referred to as a mutation*) in one of these tumor suppressor genes have an increased risk of developing certain cancers. Not every genetic change carries this risk, however. Some variants are benign (harmless), and others are classified as a variant of uncertain significance (VUS), meaning there is not yet enough evidence to know whether the variant affects cancer risk. A VUS is not the same as a pathogenic variant, and it should not be used on its own to guide medical decisions. 

Proto-oncogenes are the genes that push your cells to grow and divide when your body needs them. When they have a variant, the cells continue to grow rapidly, turning proto-oncogenes into oncogenes. 

If you order a genetic test and the results show you have a variant in one of these genes, chances are that you inherited that variant from one or both of your parents. If you test for a variant, your parents, siblings, and children have up to a 50% chance of also having it. 

If you do not have a variant in one of these genes, you will not pass it on. Most of these genetic variants do not skip a generation. We have noted where there are exceptions to this, but your genetic counselor will be your best source of information if you have any questions. 

*Note: The terms “mutation” and “variant,” when used in the context of genetics, mean the same thing. We have used “variant” throughout this resource to reflect the terminology you are more likely to see in your reports. 

ATM stands for ataxia telangiectasia mutated, and it regulates cell responses to DNA damage. It is a tumor suppressor gene that also oversees downstream proteins, such as P53, BRCA1, CHEK2, and others. 

If both ATM genes do not work, you may have a condition called ataxia telangiectasia, which is a rare condition that affects the nervous system, immune system, and other bodily systems. 

People who are born with a variant in this gene have an increased risk of developing: 

  • Breast Cancer 
  • Colorectal Cancer 
  • Ovarian Cancer 
  • Pancreatic Cancer 
  • Prostate Cancer 

BARD1 stands for BRCA1-associated RING domain 1, which signals its relationship to the tumor-suppressor gene BRCA1. The interactions between these genes regulate cell growth in the breast and ovaries. 

People who are born with a variant in this gene have an increased risk of developing: 

  • Breast Cancer 
  • Ovarian Cancer 

BRCA stands for BReast CAncer – the numbers denote gene 1 or gene 2. 

The BRCA1 and BRCA2 genes are two of the most common genes associated with an increased risk of developing cancer. When they function properly, they prevent your cells from dividing uncontrollably. 

People who are born with a variant in this gene have an increased risk of developing: 

  • Breast Cancer* 
  • Ovarian Cancer 
  • Prostate Cancer 
  • Pancreatic Cancer 

If both parents carry this mutation, you may inherit a condition called Fanconi anemia, which is a rare condition that prevents bone marrow from making enough new blood cells. In addition to the cancer risks mentioned above, people with Fanconi anemia have an increased risk of developing: 

  • Acute Myeloid Leukemia (AML)
  • Squamous Cell Carcinoma (SCC) 
  • Vulvar Cancer  

*Note: While females have a higher risk of developing breast cancer, males can also be affected. This is especially true for those with a BRCA2 gene variant. Therefore, knowledge of this inherited gene is important for both sexes.  

CDH1 stands for cadherin 1, which helps regulate cell division in the body. Some CDH1 gene variants may be associated with cleft lip or cleft palate, but not everyone with this genetic variant develops it.

People who are born with a variant in this gene have an increased risk of developing:

  • Breast Cancer – specifically lobular breast cancer 
  • Stomach Cancer – specifically diffuse gastric cancer 

CHEK2 stands for checkpoint kinase 2, since it acts as a checkpoint for cell division and responds to DNA damage. It has close interactions with other cancer-related genes such as P53, BRCA1, and TP53. Variants in this gene are associated with Li-Fraumeni syndrome.

People who are born with a variant in this gene have an increased risk of developing:

  • Breast Cancer 
  • Colorectal Cancer  
  • Kidney Cancer 
  • Prostate Cancer 
  • Thyroid Cancer 

The name DICER1 is not an acronym like other genes on this list. Rather, it receives its name from the way it acts as it dices across RNA molecules. It encodes proteins that repress certain genes from expressing in the body.

People who are born with a variant in this gene have an increased risk of developing:

  • Lung Cancer 
  • Kidney Cancer 
  • Ovarian Cancer 
  • Thyroid Cancer 

KRAS stands for Kirsten rat sarcoma, and it is a gene that signals an on/off switch to cells to tell them when to grow, mature, or die. When there is a variant in this gene, cancer cells are more likely to develop since this switch no longer functions as it should.

A variant in the KRAS gene is one of the most common oncogenic gene drivers in people, occurring in about 5% of all people diagnosed with cancer. The mutation causes a single letter change in the DNA to change “G” to “A,” which causes constant cell growth.

People who are born with a variant in this gene have an increased risk of developing:  

  • Acute Myeloid Leukemia (AML)  
  • Colorectal Cancer 
  • Lung Cancer 
  • Gallbladder Cancer  
  • Pancreatic Cancer 

LZTR1 stands for leucine-zipper-like transcriptional regulator 1. This gene instructs proteins in the Golgi apparatus, which is a structure in the cells that modifies, sorts, and transports proteins.  

It is closely related to the SMARCB1-gene which causes schwannomatosis. Schwannomatosis impacts the peripheral and spinal nerves and might cause benign tumor formation, but these do not usually develop into cancer.  

People with this genetic variant in this gene have an increased risk of developing:  

  • Brain Cancer (Glioblastoma)  
  • Schwannomas (Tumors) 

PALB2 stands for partner and localizer of BRCA2, which signals its close relationship with the BRCA2 gene. It helps the BRCA genes repair broken or damaged DNA inside cells. 

People who are born with a variant in this gene have an increased risk of developing: 

  • Breast Cancer 
  • Ovarian Cancer 
  • Pancreatic Cancer 
  • Prostate Cancer 

PTEN stands for phosphate and tensin homolog, and people with a mutation in this gene have a syndrome called “PTEN hamartoma tumor syndrome” (PHTS). It is also associated with Cowden syndrome. 

Noncancerous tumors can form in people who have this genetic variant, including in the breast, skin, mouth, intestines, thyroid, and uterus. PHTS has a wide range of symptoms that are extremely variable, so there is no way to be sure if you have it unless you undergo genetic testing. 

People who are born with a variant in this gene have an increased risk of developing: 

  • Breast Cancer 
  • Colorectal Cancer 
  • Kidney Cancer 
  • Skin Cancer 
  • Thyroid Cancer 
  • Uterine (Endometrial) Cancer 

RAD51C stands for radiation-sensitive mutant 51, with the letter C or D designating the gene duplication behavior (paralog). You inherit one RAD51C and one RAD51D gene from each parent, so one or both can have a mutation. 

People with the RAD51C variant may develop Fanconi anemia, which is a rare disorder that impacts blood cell production in the bone marrow. 

People who are born with a variant in these genes have an increased risk of developing: 

  • Breast Cancer 
  • Ovarian Cancer 

RB1 stands for retinoblastoma 1. Retinoblastoma is a rare eye cancer that usually develops in children before the age of five. 

This gene gives instructions to make a protein called pRB that stops cells from dividing too quickly; when this gene is not functioning properly, it can lead to cancer. 

People who are born with a variant in this gene have an increased risk of developing:  

  • Retinoblastoma (Eye Cancer)  
  • Sarcoma 

The TP53 gene stands for tumor protein p53. A variant in this gene is associated with Li-Fraumeni syndrome, which is a rare hereditary syndrome that predisposes people to cancer. 

People who are born with a variant in this gene have an increased risk of developing:  

  • Breast Cancer 
  • Brain Tumors 
  • Colorectal Cancer 
  • Leukemia 
  • Lung Cancer 
  • Prostate Cancer 
  • Sarcoma 
  • Skin Cancer 
  • Stomach Cancer 
  • Thyroid Cancer 

Hereditary Syndromes

Hereditary cancer syndromes are patterns of conditions that run in families that affect a person’s risk of developing cancer in their lifetime. They account for only a small share of all cancers, but they can often cause cancer at younger ages or more than one cancer in the same person. Identifying these syndromes through genetic counseling and testing can help guide screening, prevention, and treatment choices for patients and their relatives.

Down syndrome (also referred to as trisomy 21) is a common genetic disorder that occurs in people who are born with an extra copy of chromosome 21. This means that people with this syndrome have 47 total chromosomes in their bodies as opposed to 46. 

The condition changes the way children develop and grow and can put people at a higher risk of developing these cancers:  

  • Acute Lymphoblastic Leukemia (ALL) 
  • Acute Myeloid Leukemia (AML)  

Despite having a higher risk of developing ALL and AML, people with Down syndrome have a lower risk of developing other types of cancer compared to the general population. Cancers at lower risk of development include solid tumors, prostate cancer, breast cancer, and uterine cancer.  

These stand for familial adenomatous polyposis (FAP) and attenuated familial adenomatous polyposis (AFAP), which are formed from a mutation in the APC gene. Anyone can have FAP or AFAP even if it doesn’t run in their family, since the APC gene can mutate during fetal development. 

People with FAP have a very high chance of developing polyps in their colon, which can increase their risk of developing colon cancer at a young age. It can also cause other issues in the gastrointestinal system, since tumors might form in the stomach, small intestine, bone, skin, and soft tissue. 

People with this condition have a higher risk of developing these cancers:  

  • Breast Cancer 
  • Colorectal Cancer 
  • Desmoids (Tumors)  
  • Liver Cancer 
  • Stomach Cancer 

FAMMM stands for familial atypical multiple mole melanoma, and it is caused when a mutation occurs in the CDKN2A (also known as p16) and/or CDK4 genes. It is usually recognized if a person has 50 or more skin moles or birthmarks on their skin. 

People with this condition have a higher risk of developing these cancers:  

  • Skin Cancer 
  • Pancreatic Cancer 

Also known as nevoid basal cell carcinoma syndrome, Gorlin syndrome is a rare inherited disorder that can affect many different tissues and organs in a person’s body. It is caused by a mutation of the PTCH1 gene. It is usually recognized by abnormalities of the spine, ribs, or skull; eye problems or developmental problems; unusual facial features; or small pits in the skin on the hands and feet. 

People with this condition have a higher risk of developing these cancers:  

  • Brain Tumors 
  • Skin Cancer (Basal Cell Carcinoma)  

Also referred to as hereditary nonpolyposis colon cancer (HNPCC), Lynch syndrome is an autosomal dominant disorder that is commonly associated with an increased risk of colon cancer. It occurs when there is a variant in the MLH1, MSH2, MSH6, PMS2, or EPCAM genes. 

People with this disorder are also at an increased risk of developing:  

  • Brain Tumors 
  • Colorectal Cancer 
  • Ovarian Cancer 
  • Pancreatic Cancer 
  • Prostate Cancer 
  • Stomach Cancer 
  • Uterine (Endometrial) Cancer  

MAP stands for MYH-Associated Polyposis, which is an inherited condition caused by variant in the MUTYH gene. It can lead to the development of several polyps in the colon that increase the risk of colon cancer. 

MAP is different from other inherited genetic traits. It is a recessive syndrome, so both parents must pass on the gene for MAP to develop. People who inherit only one MUTYH variant have only a slight increased risk of developing cancer. 

People with this syndrome have an increased risk of developing:  

  • Bladder Cancer 
  • Colorectal Cancers 
  • Ovarian Cancer 
  • Small Intestine Cancer 

These stand for multiple endocrine neoplasia type 1 and 2, and they are hereditary conditions that cause gene variant in the RET gene. They increase the risk of developing cancers and other conditions in the endocrine system. 

This disorder is not always hereditary. The RET gene variant can be inherited from one or both parents, or the gene variant can occur during fetal development. 

People with this syndrome have an increased risk of developing:  

  • Thyroid Cancer 
  • Other tumors (benign or malignant) in the endocrine system  

These stand for neurofibromatosis Type 1 and 2, and they are genetic conditions also known as von Recklinghausen disease. They are recognized by skin discoloration or the development of noncancerous tumors on the skin, nerves, or bones. 

This disease happens when a variant in the gene NF1 occurs, which makes a protein called neurofibromin. It does not always get inherited from your parents — sometimes, the gene variant can occur during fetal development. 

Patients at Siteman benefit from WashU Medicine’s specialized clinic in Neurofibromatosis (NF) conditions. WashU Medicine researchers and physicians are experts in this uncommon disease and have a team of experts who provide specialized care. 

People with NF1 have an increased risk of developing:  

  • Brain Tumors 
  • Breast Cancer 
  • Sarcomas 
  • Pheochromocytomas 

People with NF2 have an increased risk of developing:  

  • Brain Tumors 
  • Schwannomas 

Puetz-Jeghers syndrome (PJS) is a rare, inherited disorder sometimes caused by a mutation in the STK11 gene that forms in the lining of the gastrointestinal tract. It can cause dark-colored spots around the mouth, eyes, and nose.  

People with this syndrome have an increased risk of developing:  

  • Breast Cancer 
  • Cervical Cancer 
  • Gastrointestinal Cancers 
  • Lung Cancer 
  • Ovarian Cancer 
  • Pancreatic Cancer 

Rothmund-Thomson syndrome is a rare, inherited disorder that causes rashes that begin on the face during infancy and can spread over a person’s lifetime to other parts of the body. 

People with this syndrome have an increased risk of developing:  

  • Sarcoma 
  • Skin Cancer 

Tuberous sclerosis complex (TSC) is a genetic disease that causes tumors and symptoms in multiple organs of the body including the brain, skin, eyes, kidneys, heart, and lungs.  

WashU Medicine physicians at Siteman lead in TSC treatment and research with a multidisciplinary team that sees patients with this disease. Learn more about the Tuberous Sclerosis Center and Clinic at WashU Medicine, which is one of only a few around the country.   

People with this disease have an increased risk of developing:  

  • Kidney Cancer 
  • Other Tumors (mostly benign) 

XP is an inherited disorder that stands for xeroderma pigmentosum. It causes extreme sensitivity to sunlight, impacting the sensitivity of the skin and eyes to UV rays. In some cases, XP can develop into other abnormalities in the nervous system and can impact hearing. 

People with this syndrome have an increased risk of developing:  

  • Eye Cancer 
  • Skin Cancer 

Genes + Hereditary Terms

Understanding how genes and your DNA function can empower you to be proactive about your health. Below are some of the terms commonly used around hereditary cancers and genetic syndromes.

An allele is a version of a gene inherited from your biological parents. You inherit one from each parent, and they can be the same or different. These determine certain traits, such as hair type, eye color, or blood type.  

A carrier is a term referring to someone who “carries” a genetic variant, but whose body does not have the condition or disease it is associated with. Even though they do not show it, carriers can pass the genetic variant on to their children. 

Chromosomes are where DNA lives in a tightly wound structure. Humans inherit 23 chromosomes from each parent, for a total of 46. All chromosomes are present in every cell of the body.  

DNA stands for deoxyribonucleic acid, and it is the chemical code that lives in each of the body’s trillions of cells. It composes the genetic code in a double helix structure and gives the body instructions on how to operate.  

Dominant genes are a version of a gene that a person expresses, even if only one copy of it is inherited from their parents. They cause an effect or increase the risk of developing a disease or disorder. 

Enzymes are a type of protein or RNA molecule that speed up a chemical reaction in the cell. They can be used repeatedly since they are not destroyed during the process.  

Epigenetics refers to the changes in DNA that are caused by environmental exposures that do not change the genetic code but do change the chemical structure. Epigenetic changes can be acquired during a person’s life or passed on to children.  

Genes act like a reference for the cells that tell them how to grow, how often to replicate, how they should function, and how they should repair themselves or be eliminated. 

You inherit one copy of each gene from both of your parents.  

Genetic mutations are also referred to as variants– they refer to any change in the DNA sequence of a gene. Some variants are harmless; others might increase your risk of developing a disease or disorder, while others cause a disease or disorder directly.   

Genetic tests are lab tests, usually taken from a sample of blood or saliva, that analyze a person’s DNA to check for specific genetic variants.  

Germline mutations or variants are present in the egg or sperm from your biological parents that are passed on to your DNA when you are conceived. 

Heterozygous alleles (or versions of a gene) are two different versions, meaning you inherited one typical version of the gene and one atypical version of the gene from your other biological parent.  

Homozygous alleles (or versions of a gene) are two identical copies of genes you receive from your biological parents. Both of the alleles can be a genetic variants or a typical gene. 

A pedigree is a family history chart that doctors use to record medical conditions in blood relatives. They use these to help a person assess any chances of carrying an inherited gene or hereditary syndrome.  

Proteins are molecules that follow instructions from genes. They carry out the work of controlling cellular growth, repairing damage, and ordering when a cell should be eliminated.  

Proto-oncogenes are genes that control the growth and division of cells. Proto-oncogenes that are variants or mutations get stuck in the “on” position, causing abnormal cell growth and division. When this happens, they are called oncogenes.  

Recessive genes are variants in genes that will express depending on whether the person inherits them from one parent or both. If they inherit them from one, the other copy of the gene will make up for the variant; if both parents pass on the variants, the person will show a noticeable effect.  

Somatic mutations or variants alter your DNA during a person’s lifetime and are not inherited from your biological parents.  

A syndrome is a pattern of conditions that usually occurs due to an underlying genetic variant or variants.  

Tumor suppressor genes are genes that control the speed, rate, and quality of cell division. They can repair DNA mistakes and eliminate damaged cells. When functioning normally, they prevent cancer from developing. Tumor suppressor genes that are variants or mutations can raise a person’s cancer risk.  

A variant of unknown significance (VUS) is a result you might receive from a genetic test, which means that it is unknown whether the genetic variant raises the risk of cancer or not.  

How To Use This Information

The content on this page is for informational purposes only and does not replace having a conversation with your doctor. To know if you have a genetic variant or hereditary syndrome, see a genetic counselor. They will look at your family and medical history to help you. 

Genetic counselors can help you through the process of ordering a genetic test, interpreting your results, and guiding your treatment.  

Start Here. Get the Care You Need.

Our Siteman care coordinators – oncology-trained nurses who help with scheduling, finding the right specialist, and guidance – can help you through the process.

Call us directly or submit a form, and we will call you back.

Call Us (800) 600-3606

Frequently Asked Questions

Your genetic counselor will be your best source of information about what you can do to detect potential cancer earlier. Some people might be recommended a surveillance program where you will have regular appointments to check in on your health. In other cases, you might be recommended screening programs earlier than the general public. Depending on your health background and risk profile, a doctor might even recommend preventive treatments or surgery.  

No matter what your genetic counselor recommends, it’s also a good idea to avoid known carcinogens that increase your risk of cancer. That includes excess UV ray exposure, quitting smoking, and other behaviors that are under your control. 

Explore Siteman’s 8ightways to prevent cancer

If you test positive for a genetic variant that increases your risk of cancer, that means your closest biological relatives (including your parents, siblings, and children of any gender) have a 50-50 chance of having the same genetic variant, too. More distant relatives might also carry the same genetic variant.   

Letting your family know about a positive test result can empower them to undergo testing to see if they get the same results. You can share your documentation with them so they can order the same type of genetic test from their doctor, or they can meet with a genetic counselor in their network to see if there are other tests that are better suited for them.  

Some genetic variants increase a child’s risk of cancer, but not all of them. In most cases, you can wait until your child is 18 to let them decide for themselves if they want to undergo genetic testing.  

Your genetic counselor will provide you with more information about your specific test results and the implications for your family’s shared risk. They can also help you with the emotional implications of communicating with your family about your results, which is easier for some people than for others.  

A VUS result is common to see on a genetic test. It means the DNA sequencing test found a genetic variant, but there is no certainty about its causal relationship to a disease. You do not need to make any medical decisions based on a VUS result.  

Genetic science is an evolving field, so over time, scientists might uncover new knowledge about these genetic variants. Your genetic counselor will contact you if information becomes available that is actionable, but if you’d like to retest or check your samples as new discoveries unfold, you can call your genetic counselor to go over your options.  

Cancer screening is an important tool to detect cancer early. Catching cancer early means treating it before it has the chance to spread or develop further abnormalities.  

Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine has a number of screening programs on our campus, as well as mobile screening options that travel to different areas in the community.  

You can start by getting in touch with our care coordinators. They are nurses trained in oncology with years of clinical experience and serve as a consistent point of contact during your journey. They have inside knowledge of the health systems and different genetic health clinics and their offerings, including their times and locations, and have direct access to care teams.  

They know all the right doctors for all the right care – and how to coordinate your needs better than a call center. You do not need a referral to get started.  

 

Make an appointment  

Clinically reviewed by:

Updated November 13, 2026